Stratifying by clinicopathologic features, STIP1 was upregulated in ESCCs with greater lymph node involvement (Figure 1L), larger tumor size (Figure 1M), and more advanced clinical stage (Figure 1N) (Table 1). Here, STIP1 is linked to neoplasm.